Safety in Immunomodulatory Functions of Alemtuzumab (Campath) in Pediatric Kidney Transplantation Recipients

Name: Safety in Immunomodulatory Functions of Alemtuzumab (Campath) in Pediatric Kidney Transplantation Recipients
Published: 2005
License: Public Domain

National Institute of Allergy and Infectious Diseases (NIAID) · 2005

ClinicalTrials.gov · Datasets · License: Public Domain · 2005

Open Source ↗

chronic immunosuppression kidney-failure kidney-transplantation

kidney failure, chronic, kidney transplantation, immunosuppression, end stage renal disease, renal transplantation, kidney failure, pediatric renal transplant recipients, alemtuzumab, campath, mycophenolate mofetil, mmf, cellcept

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 893487
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.